Use of Argatroban for anticoagulation during cardiopulmonary bypass in a patient with heparin allergy

被引：14

作者：

Smith, Alan I. ^{[1
]}

Stroud, Robert ^{[1
]}

Damiani, Peter ^{[1
]}

Vaynblat, Mikhail ^{[1
]}

机构：

[1] Maimonides Hosp, Div Cardiothorac Surg, Brooklyn, NY 11219 USA

来源：

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY | 2008年 / 34卷 / 05期

关键词：

CPB; Anticoagulation; Mitral valve replacement;

D O I：

10.1016/j.ejcts.2008.07.035

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The use of Argatroban for treatment of heparin-induced thrombocytopenia (HIT) and for percutaneous coronary intervention in patients with HIT is well described and FDA approved. The use of Argatroban for cardiopulmonary bypass remains off label and the subject of a few case reports. We report the case of a patient with a heparin allergy requiring cardiopulmonary bypass (CPB) for mitral valve replacement. Argatroban was successfully used as anticoagulation for CPB. (C) 2008 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

引用

页码：1113 / 1114

页数：2

共 50 条

[21] HEPARIN ANTICOAGULATION DURING CARDIOPULMONARY BYPASS IN AN ANTI-THROMBIN-III DEFICIENT PATIENT - IMPLICATIONS RELATIVE TO THE ETIOLOGY OF HEPARIN REBOUND
SOLOWAY, HB
CHRISTIANSEN, TW
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1980, 73 (05) : 723 - 725
[22] Use of plasma exchange and heparin during cardiopulmonary bypass for a patient with heparin induced thrombocytopenia: A case report
Kajitani, M
Aguinaga, M
Johnson, CE
Scott, MA
Antakli, T
JOURNAL OF CARDIAC SURGERY, 2001, 16 (04) : 313 - 318
[23] Heparin desensitisation prior to cardiopulmonary bypass in a patient with alpha-gal allergy
McRae, A. S.
Tidwell, W. P.
Patel, S.
Lombard, F. W.
ANAESTHESIA REPORTS, 2022, 10 (02)
[24] ANCROD (ARVIN) AS AN ALTERNATIVE TO HEPARIN ANTICOAGULATION FOR CARDIOPULMONARY BYPASS
ZULYS, VJ
TEASDALE, SJ
MICHEL, ER
SKALA, RA
KEATING, SE
VIGER, JR
GLYNN, MFX
ANESTHESIOLOGY, 1989, 71 (06) : 870 - 877
[25] Cardiopulmonary bypass for complex cardiac surgery using bivalirudin anticoagulation in a patient with heparin antibodies
Huebler, M
Koster, A
Buz, S
Boettcher, W
Hetzer, R
Kuppe, H
Dyke, CM
JOURNAL OF CARDIAC SURGERY, 2006, 21 (03) : 286 - 288
[26] The use of argatroban as an anticoagulant for cardiopulmonary bypass in cardiac operations
Furukawa, K
Ohteki, H
Hirahara, K
Narita, Y
Koga, S
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2001, 122 (06): : 1255 - 1256
[27] The Use of Bivalirudin for Cardiopulmonary Bypass Anticoagulation in Pediatric Heparin-Induced Thrombocytopenia Patients
Gates, Richard
Yost, Paul
Parker, Beth
ARTIFICIAL ORGANS, 2010, 34 (08) : 667 - U2
[28] Management of anticoagulation during cardiopulmonary bypass in a patient with a circulating lupus anticoagulant
Ducart, AR
Collard, EL
Osselaer, JC
Broka, SM
Eucher, PM
Joucken, KL
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 1997, 11 (07) : 878 - 879
[29] Effective anticoagulation by argatroban during coronary stent implantation in a patient with heparin-induced thrombocytopenia
Suzuki, S
Sakamoto, S
Koide, M
Matsuo, M
Fujii, K
Matsuo, T
THROMBOSIS RESEARCH, 1997, 88 (06) : 499 - 502
[30] Alternatives to heparin and protamine anticoagulation for cardiopulmonary bypass in cardiac surgery
Bouraghda, Aurore
Gillois, Pierre
Albaladejo, Pierre
CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2015, 62 (05): : 518 - 528

← 1 2 3 4 5 →